NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Newsletters
Advertisement
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HONcode
Security by Verisign

Acute Cholecystitis


Return to Library

Free Acute Cholecystitis Articles


New findings from National Taiwan University in the area of cholecystitis published



2009 MAY 18 - (NewsRx.com) -- "The optimal timing of laparoscopic cholecystectomy (LC) in the treatment of acute cholecystitis remains controversial. This retrospective study was undertaken to assess the clinical outcomes, possible advantages and disadvantages of early versus delayed LC for acute cholecystitis," scientists writing in the journal Hepato - Gastroenterology report.

"Records of all patients admitted for acute cholecystitis in whom laparoscopic cholecystectomy was attempted between January 2004 and January 2006, at National Taiwan University Hospital were reviewed. A total of 89 patients were recruited to the study. Of these, 56 patients received early laparoscopic cholecystectomy (ELC), and 33 patients received delayed laparoscopic cholecystectomy (DLC) following conservative therapy. There were no intergroup differences in age, gender, or days of symptoms prior to presentation. Patients undergoing ELC experienced a significantly longer operation time (109 +/- 37.59 minutes versus 77 +/- 25.65 minutes, p<0.001), more blood loss (76ml versus 28ml, p=0.006) and a longer post-operation hospital stay (4.5 days versus 2.6 days, p<0.001). The conversion rate to open cholecystectomy was not significantly different (4/56 versus 2/33, p=0.84), and there were no biliary tract injury or other major complications in either group. However, patients with ELC had a shorter total hospital stay (4.53 days versus 7.79 days, p<0.001) and fewer admission times (1 time in ELC versus 2.4 times in DLC, p<0.001). Both early and delayed LC appears to be effective and safe in the treatment of acute cholecystitis. Early LC may be more technically demanding and time-consuming, and may be associated with a higher rate of wound infections; however, it also tends to shorten the total length of hospital stay and reduce the risk of repeat cholecystitis," wrote T.C. Chang and colleagues, National Taiwan University.

The researchers concluded: "We recommend early LC for acute cholecystitis comparison with delayed LC."

Chang and colleagues published their study in Hepato - Gastroenterology (Evaluation of Early Versus Delayed Laparoscopic Cholecystectomy in the Treatment of Acute Cholecystitis. Hepato - Gastroenterology, 2009;56(89):26-28).

Additional information can be obtained by contacting P.H. Lee, National Taiwan University, Dept. of Surgery, 7 Chung Shan S Rd., Taipei 100, Taiwan.

The publisher of the journal Hepato - Gastroenterology can be contacted at: H G E Update Medical Publishing S a, PO Box 17257, Athens GR-10024, Greece.

Keywords: Taiwan, Taipei, Acute Cholecystitis, Cholecystitis, Clinical Trials, Gastroenterology, Laparoscopic Cholecystectomy, Laparoscopy, Post-Trials Research, Surgery, Therapy, Treatment, National Taiwan University.

This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login